Latest Articles

Publication Date
"Women Have Had To Suffer In Silence": Sophie Dillman Demands Change For Endometriosis - Refinery29

"Women Have Had To Suffer In Silence": Sophie Dillman Demands Change For Endometriosis Refinery29

Published: March 13, 2026, 5:53 a.m.
Evaluation of ChatGPT and Gemini in Answering Patient Questions after Gynecologic Surgery.

To explore the performance of ChatGPT version 4.0 (GPT-4) and Gemini Advanced (Gemini) large language models (LLMs) in addressing common patient questions after gynecology surgery with regards to accuracy, relevance, …

Published: Feb. 24, 2026, midnight
Uterine Arteriovenous Malformations: An Underrecognized Putative Cause of Postpartum Hemorrhage, Abnormal Uterine Bleeding, and Pelvic Pain.

Arteriovenous malformations (AVMs) are vascular anomalies defined by direct communications between arteries and veins with bypassing of the capillary network. Such lesions may be congenital or acquired. In the uterus, …

Published: Feb. 20, 2026, midnight
Immunohistochemical Detection of the Mechano-Gated Piezo Channels in the Normal Endometrium and in Endometriosis.

Endometriosis is an inflammatory estrogen-dependent disorder characterized by pain, dyspareunia, dysmenorrhea, and infertility. This is due to the invasion of different organs by endometrial tissue that causes inflammation, angiogenesis, and …

Published: Jan. 19, 2026, midnight
Unraveling the VEGF-ETS1 axis: a transcriptomic and single-cell analysis of angiogenesis in endometriosis.

Endometriosis (EM) is a chronic inflammatory gynecological disorder characterized by ectopic endometrial-like lesions, where aberrant angiogenesis is a hallmark driving lesion establishment and progression. However, the transcriptional mechanisms underlying pathological …

Published: Jan. 16, 2026, midnight
Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled Development Candidate, Targeting CDK11 - Sahm

Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled Development Candidate, Targeting CDK11 …

Published: Jan. 9, 2026, 6:18 a.m.
Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled Development Candidate, Targeting CDK11 - The Manila Times

Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled Development Candidate, Targeting CDK11 …

Published: Jan. 8, 2026, 12:53 p.m.
Hallmark Star Sees ‘Light at the End of the Tunnel’ After Surgery - EntertainmentNow

Hallmark Star Sees ‘Light at the End of the Tunnel’ After Surgery EntertainmentNow

Published: Dec. 28, 2025, 7:48 p.m.
Hallmark Star Janel Parrish Shares Endometriosis Surgery Recovery to Raise Awareness - Zoom Bangla News

Hallmark Star Janel Parrish Shares Endometriosis Surgery Recovery to Raise Awareness Zoom Bangla News

Published: Dec. 28, 2025, 7:18 p.m.
Hallmark Star Janel Parrish Shares Endometriosis Surgery Recovery to Raise Awareness - inews.zoombangla.com

Hallmark Star Janel Parrish Shares Endometriosis Surgery Recovery to Raise Awareness inews.zoombangla.com

Published: Dec. 28, 2025, 7:18 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!